Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
Kasper B, Achee A, Schuster K, Wilson R, van Oortmerssen G, Gladdy RA, Hemming ML, Huang P, Ingham M, Jones RL, Pollack SM, Reinke D, Sanfilippo R, Schuetze SM, Somaiah N, Van Tine BA, Wilky B, Okuno S, Trent J. Kasper B, et al. Among authors: van oortmerssen g. Cancers (Basel). 2021 Feb 20;13(4):886. doi: 10.3390/cancers13040886. Cancers (Basel). 2021. PMID: 33672607 Free PMC article. Review.
Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data.
den Hollander D, Dirkson AR, Verberne S, Kraaij W, van Oortmerssen G, Gelderblom H, Oosten A, Reyners AKL, Steeghs N, van der Graaf WTA, Desar IME, Husson O. den Hollander D, et al. Among authors: van oortmerssen g. Support Care Cancer. 2022 Jun;30(6):5137-5146. doi: 10.1007/s00520-022-06929-3. Epub 2022 Mar 2. Support Care Cancer. 2022. PMID: 35233640 Free PMC article.
Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study.
Dirkson A, den Hollander D, Verberne S, Desar I, Husson O, van der Graaf WTA, Oosten A, Reyners AKL, Steeghs N, van Loon W, van Oortmerssen G, Gelderblom H, Kraaij W. Dirkson A, et al. Among authors: van oortmerssen g. JMIR Form Res. 2022 Dec 15;6(12):e36755. doi: 10.2196/36755. JMIR Form Res. 2022. PMID: 36520526 Free PMC article.
Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators.
Westerdijk K, Steeghs N, Tacke CSJ, van der Graaf WTA, van Erp NP, van Oortmerssen G, Hermens RPMG, Desar IME; Dutch Pharmacology Oncology Group (DPOG). Westerdijk K, et al. Among authors: van oortmerssen g. Cancer Med. 2023 Nov;12(22):21041-21056. doi: 10.1002/cam4.6663. Epub 2023 Oct 30. Cancer Med. 2023. PMID: 37902257 Free PMC article.